Wang Ling

Wang Ling


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2022 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
WLWang Ling
Wang Ling
YSYuanyuan Sun
Yuanyuan Sun
FKFang Kong
Fang Kong
YJYi Jiang
Yi Jiang
MAMengmeng An
Mengmeng An
PGPing Gong
Ping Gong

9 December 2022 in Cryobiology
Verified
Journal Article
Closed access
DWDongxia Wang
Dongxia Wang
WLWang Ling
Wang Ling
YSYuanyuan Sun
Yuanyuan Sun
FKFang Kong
Fang Kong
YJYi Jiang
Yi Jiang
YYYanzong Yang
Yanzong Yang

8 July 2022 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
ZFZheyuan Fan
Zheyuan Fan
WLWang Ling
Wang Ling
JWJin Wang
Jin Wang
CGChundong Gu
Chundong Gu
Thymic neoplasms are rarely seen among patients with multiple endocrine neoplasia type 1 (MEN1) and appear to be especially rare when pathological examination reveals a World Health Organization Type AB thymoma. In the case presented here, we report a 39-year-old woman with Type AB thymoma in MEN1. A 7.8-cm-sized mediastinal mass was diagnosed as a thymic neoplasm by computed tomography. In addition, pituitary tumor and hypercalcemia from parathyroid hyperplasia were found. Therefore, the patient was clinically diagnosed with MEN1 syndrome and underwent surgical resection of thymic tumor. At the 1-year follow-up, the patient appeared to be healthy without any sign of reoccurrence. Despite its rare occurrence, our case provides us with a new awareness that thymoma may coexist with MEN1.

1 January 2026 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
PLPeijuan Li
Peijuan Li
ZSZhangping Sun
Zhangping Sun
YCYushu Chen
Yushu Chen
ZFZhen Fang
Zhen Fang
DYDongping Yu
Dongping Yu
PGPing Gong
Ping Gong

21 August 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
YCYushu Chen
Yushu Chen
YLYing Liu
Ying Liu
NLNa Li
Na Li
WLWang Ling
Wang Ling
PLPeijuan Li
Peijuan Li
PGPing Gong
Ping Gong
Background: In cardiac arrest (CA) patients undergoing cardiopulmonary resuscitation (CPR), neuroinflammation following return of spontaneous circulation (ROSC) contributes to brain ischemia/reperfusion injury and neurological dysfunction. Recent evidence suggested that neuraminidase could exacerbate inflammatory responses by disrupting CD24‐Siglec‐G/10 immune checkpoint axis. As a neuraminidase inhibitor, oseltamivir phosphate (OP) holds potential for immunomodulation beyond its antiviral use. We aimed to investigate the impact and mechanism of OP on neuroinflammation regulation after ROSC.Methods: Male pigs were randomized into the sham control group, CPR, and CPR + OP group. CA was induced in pigs through 8 min of untreated ventricular fibrillation. Brains were harvested for assessing serum inflammatory markers and neuronal damage at 24 h after ROSC. BV2 microglial underwent oxygen–glucose deprivation/reperfusion (OGD/R). Effects of OP on inflammatory responses, NF‐κB activation, cell viability, and the CD24‐Siglec‐G/10 interaction were evaluated using immunofluorescence, immunoprecipitation, molecular, and biochemical assays.Results: In vivo, OP attenuated pig cerebral microglial activation and neuronal integrity with attenuated neuroinflammation, alongside time‐dependent neuraminidase activity increases. In vitro, OP suppressed OGD/R‐induced microglial NF‐κB activation, reduced pro‐inflammatory cytokine levels, and preserved CD24‐Siglec‐G interaction, correlating with diminished neuraminidase release.Conclusions: OP as a repurposed immunomodulator that suppresses microglial‐driven neuroinflammation after CA by preserving sialylation‐dependent CD24‐Siglec‐G/10 interaction.